Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.
<h4>Background</h4>There is currently no consensus regarding the optimal number of chemotherapy cycles to be administered before and after interval debulking surgery (IDS) in patients with advanced ovarian cancer. This study aimed to evaluate the impact of the number of neoadjuvant chemo...
Saved in:
| Main Authors: | Young Shin Chung, Yun-Ji Kim, Inha Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183754&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of clinical trial participation on the survival of patients with newly diagnosed advanced ovarian cancer
by: Yong Jae Lee, et al.
Published: (2025-05-01) -
Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer
by: Yoon Suk Lee, et al.
Published: (2025-01-01) -
Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis
by: Soo-Young Lee, et al.
Published: (2025-04-01) -
Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix
by: Hyerim Eum, et al.
Published: (2024-07-01) -
Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer
by: Tsuyoshi Shinohara, et al.
Published: (2013-01-01)